186 research outputs found

    La Cova de sa Tossa Alta (Escorca, Mallorca): una estació prehistòrica remota a la serra de Tramuntana

    Get PDF
    [eng] The results of the excavation of test pits in Cova de sa Tossa Alta (Escorca, Mallorca) are presented in this paper. A stratigraphic sequence spreading over the Bronze and Iron Ages has been obtained. The earliest documented level is associated to the 14C date Wk 28753 (3421 ± 33 BP; 1880 – 1620 2σ cal BC). It has not been found any evidence for a previous occupation of the cave. The attribution by other scholars to the Chalcolithic Age of several sherd fragments obtained at the surface of the cave is not supported by the new evidence. The use of the cave and its preparation for stabling cows probably corresponds to late times of the prehistory of Mallorca. A lithic industry without known parallels in contemporary mainland Western Europe is briefly described.[cat] Presentam els resultats de l’excavació de diferents cales a la cova de sa Tossa Alta (Escorca, Mallorca). Hem obtingut un perfil estratigràfic que abasta l’Edat de Bronze i l’Edat de Ferro. El nivell d’ocupació més antic documentat està associat a la datació Wk 28753 (3421 ± 33 BP; 1880 – 1620 2σ cal BC). No s’hi ha obtingut cap evidència d’una ocupació anterior. L’atribució de materials ceràmics al Calcolític no es troba suportada per l’evidència disponible. L’ús de la cova i el seu condicionament per estabular vaques probablement correspon a moments tardans de la prehistòria de Mallorca. Es documenta una indústria lítica que no sembla tenir paral·lels coetanis al continent europeu

    Evaluation of the incorporation of waste generated from titanium dioxide manufacturing in red ceramics

    Get PDF
    Rotary-vacuum-filter mud (RVFM) is waste generated during the manufacturing process of titanium dioxide. In this work, RVFM and ceramic bricks containing different ratios of this waste are investigated. The mud samples were characterized using thermal analysis (TG/DTG). The aim of the present work was to determine the effect of adding RVFM on the ceramic properties of clay, such as apparent porosity, water absorption, linear shrinkage and flexural strength, used to produce red ceramics (bricks and roofing tiles). Samples were dried out at 110°C and fired at 800°C, 950°C and 1100°C. The addition of RVFM tends to increase the apparent porosity and water absorption and to decrease the flexural strength of the ceramic specimens. Based on the results, ceramic specimens with 20% RVFM content that are burned at 800ºC can not be used as bricks, and ceramic specimens with 20% RVFM content that are fired at 800ºC and 950°C can not used as roofing tiles, according to Brazilian standards

    Influence of crystalline structure on the luminescence properties of terbium orthotantalates.

    Get PDF
    Terbium orthotantalate powders were produced with M-fergusonitetype (I2/a) and M0-fergusonite type (P2/a) structures.The samples were studied byX-ray diffraction, Ramans cattering, and photo luminescence measure ments (emission and decaycurves).The results showed that crystalline materials were obtained with all the 18Raman-active modes predicted by group theory alculations. Also, it was observed through photo luminescence ecay curves that the Tb3? ions occupies only one- symmetry site in both crystal lographi arrangements. Photo luminescence emission curves exhibited some variation inspectral shape, peak position, and relative intensity asa consequence of their different crystal linear rangements. The dominated emission of Tb3? (5D4-7F5) is centered with a maximum intensity at 549.2nm(M-type) and 543.0nm(M0-type). Fluorescence life times for M-TbTaO4 and M0-TbTaO4 were determinedas 33.4 ms and 1.25ms, respectively. M0-type materials seems to be the most suitable for luminescent devicesand could be a potential green luminescent material dueto the strongest mission if compared with the M-fergusonite type

    Collapsing Glomerulonephritis in a Kidney Transplant Recipient after mRNA SARS-CoV-2 Vaccination

    Full text link
    With the vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), studies are describing cases of glomerulonephritis arising after vaccination. We present the first case of a kidney transplant patient who, after mRNA vaccination against SARS-CoV-2, developed nephrotic proteinuria and renal dysfunction, with a biopsy diagnostic of collapsing glomerulonephritis. No other triggers for this glomerulonephritis were identified. Antibodies against the spike protein were negative, but the patient developed a specific T-cell response. The close time between vaccination and the proteinuria suggests a possible determinant role of vaccination. We should be aware of nephropathies appearing after COVID-19 vaccination in kidney transplant recipients also

    Current gene panels account for nearly all homologous recombination repair-associated multiple-case breast cancer families

    Get PDF
    It was hypothesized that variants in underexplored homologous recombination repair (HR) genes could explain unsolved multiple-case breast cancer (BC) families. We investigated HR deficiency (HRD)-associated mutational signatures and second hits in tumor DNA from familial BC cases. No candidates genes were associated with HRD in 38 probands previously tested negative with gene panels. We conclude it is unlikely that unknown HRD-associated genes explain a large fraction of unsolved familial BC

    ISLES 2022: A multi-center magnetic resonance imaging stroke lesion segmentation dataset

    Full text link
    Magnetic resonance imaging (MRI) is an important imaging modality in stroke. Computer based automated medical image processing is increasingly finding its way into clinical routine. The Ischemic Stroke Lesion Segmentation (ISLES) challenge is a continuous effort to develop and identify benchmark methods for acute and sub-acute ischemic stroke lesion segmentation. Here we introduce an expert-annotated, multicenter MRI dataset for segmentation of acute to subacute stroke lesions (https://doi.org/10.5281/zenodo.7153326). This dataset comprises 400 multi-vendor MRI cases with high variability in stroke lesion size, quantity and location. It is split into a training dataset of n = 250 and a test dataset of n = 150. All training data is publicly available. The test dataset will be used for model validation only and will not be released to the public. This dataset serves as the foundation of the ISLES 2022 challenge (https://www.isles-challenge.org/) with the goal of finding algorithmic methods to enable the development and benchmarking of automatic, robust and accurate segmentation methods for ischemic stroke

    ISLES 2022: A multi-center magnetic resonance imaging stroke lesion segmentation dataset.

    Get PDF
    Magnetic resonance imaging (MRI) is an important imaging modality in stroke. Computer based automated medical image processing is increasingly finding its way into clinical routine. The Ischemic Stroke Lesion Segmentation (ISLES) challenge is a continuous effort to develop and identify benchmark methods for acute and sub-acute ischemic stroke lesion segmentation. Here we introduce an expert-annotated, multicenter MRI dataset for segmentation of acute to subacute stroke lesions ( https://doi.org/10.5281/zenodo.7153326 ). This dataset comprises 400 multi-vendor MRI cases with high variability in stroke lesion size, quantity and location. It is split into a training dataset of n = 250 and a test dataset of n = 150. All training data is publicly available. The test dataset will be used for model validation only and will not be released to the public. This dataset serves as the foundation of the ISLES 2022 challenge ( https://www.isles-challenge.org/ ) with the goal of finding algorithmic methods to enable the development and benchmarking of automatic, robust and accurate segmentation methods for ischemic stroke

    Genetic diversity and connectivity of southern right whales (Eubalaena australis) found in the Brazil and Chile-Peru wintering grounds and the South Georgia (Islas Georgias del Sur) feeding ground

    Get PDF
    As species recover from exploitation, continued assessments of connectivity and population structure are warranted to provide information for conservation and management. This is particularly true in species with high dispersal capacity, such as migratory whales, where patterns of connectivity could change rapidly. Here we build on a previous long-term, large-scale collaboration on southern right whales (Eubalaena australis) to combine new (nnew) and published (npub) mitochondrial (mtDNA) and microsatellite genetic data from all major wintering grounds and, uniquely, the South Georgia (Islas Georgias del Sur: SG) feeding grounds. Specifically, we include data from Argentina (npub mtDNA/microsatellite=208/46), Brazil (nnew mtDNA/microsatellite=50/50), South Africa (nnew mtDNA/microsatellite=66/77, npub mtDNA/microsatellite=350/47), Chile-Peru (nnew mtDNA/microsatellite=1/1), the Indo-Pacific (npub mtDNA/microsatellite=769/126), and SG (npub mtDNA/microsatellite=8/0, nnew mtDNA/microsatellite=3/11) to investigate the position of previously unstudied habitats in the migratory network: Brazil, SG and Chile-Peru. These new genetic data show connectivity between Brazil and Argentina, exemplified by weak genetic differentiation and the movement of one genetically identified individual between the South American grounds. The single sample from Chile-Peru had a mtDNA haplotype previously only observed in the Indo-Pacific and had a nuclear genotype that appeared admixed between the Indo-Pacific and South Atlantic, based on genetic clustering and assignment algorithms. The SG samples were clearly South Atlantic, and were more similar to the South American than the South African wintering grounds. This study highlights how international collaborations are critical to provide context for emerging or recovering regions, like the SG feeding ground, as well as those that remain critically endangered, such as Chile-Peru

    CXCR3 Antagonism of SDF-1(5-67) Restores Trabecular Function and Prevents Retinal Neurodegeneration in a Rat Model of Ocular Hypertension

    Get PDF
    Glaucoma, the most common cause of irreversible blindness, is a neuropathy commonly initiated by pathological ocular hypertension due to unknown mechanisms of trabecular meshwork degeneration. Current antiglaucoma therapy does not target the causal trabecular pathology, which may explain why treatment failure is often observed. Here we show that the chemokine CXCL12, its truncated form SDF-1(5-67), and the receptors CXCR4 and CXCR3 are expressed in human glaucomatous trabecular tissue and a human trabecular cell line. SDF-1(5-67) is produced under the control of matrix metallo-proteinases, TNF-α, and TGF-β2, factors known to be involved in glaucoma. CXCL12 protects in vitro trabecular cells from apoptotic death via CXCR4 whereas SDF-1(5-67) induces apoptosis through CXCR3 and caspase activation. Ocular administration of SDF-1(5-67) in the rat increases intraocular pressure. In contrast, administration of a selective CXCR3 antagonist in a rat model of ocular hypertension decreases intraocular pressure, prevents retinal neurodegeneration, and preserves visual function. The protective effect of CXCR3 antagonism is related to restoration of the trabecular function. These data demonstrate that proteolytic cleavage of CXCL12 is involved in trabecular pathophysiology, and that local administration of a selective CXCR3 antagonist may be a beneficial therapeutic strategy for treating ocular hypertension and subsequent retinal degeneration

    A vaccine therapy for canine visceral leishmaniasis promoted significant improvement of clinical and immune status with reduction in parasite burden.

    Get PDF
    Herein, we evaluated the treatment strategy employing a therapeutic heterologous vaccine composed of antigens of Leishmania braziliensis associated with MPL adjuvant (LBMPL vaccine) for visceral leishmaniasis (VL) in symptomatic dogs naturally infected by Leishmania infantum. Sixteen dogs received immunotherapy with MPL adjuvant (n = 6) or with a vaccine composed of antigens of L. braziliensis associated with MPL (LBMPL vaccine therapy, n = 10). Dogs were submitted to an immunotherapeutic scheme consisting of 3 series composed of 10 subcutaneous doses with 10-day interval between each series. The animals were evaluated before (T0) and 90 days after treatment (T90) for their biochemical/hematological, immunological, clinical, and parasitological variables. Our major results showed that the vaccine therapy with LBMPL was able to restore and normalize main biochemical (urea, AST, ALP, and bilirubin) and hematological (erythrocytes, hemoglobin, hematocrit, and platelets) parameters. In addition, in an ex vivo analysis using flow cytometry, dogs treated with LBMPL vaccine showed increased CD3+ T lymphocytes and their subpopulations (TCD4+ and TCD8+), reduction of CD21+ B lymphocytes, increased NK cells (CD5?CD16+) and CD14+ monocytes. Under in vitro conditions, the animals developed a strong antigen- specific lymphoproliferation mainly by TCD4+ and TCD8+ cells; increasing in both TCD4+IFN-?+ and TCD8+IFN-?+ as well as reduction of TCD4+IL-4+ and TCD8+IL-4+ lymphocytes with an increased production of TNF-? and reduced levels of IL-10. Concerning the clinical signs of canine visceral leishmaniasis, the animals showed an important reduction in the number and intensity of the disease signs; increase body weight as well as reduction of splenomegaly. In addition, the LBMPL immunotherapy also promoted a reduction in parasite burden assessed by real-time PCR. In the bone marrow, we observed seven times less parasites in LBMPL animals compared with MPL group. The skin tissue showed a reduction in parasite burden in LBMPL dogs 127.5 times higher than MPL. As expected, with skin parasite reduction promoted by immunotherapy, we observed a blocking transmission to sand flies in LBMPL dogs with only three positive dogs after xenodiagnosis. The results obtained in this study highlighted the strong potential for the use of this heterologous vaccine therapy as an important strategy for VL treatment
    • …
    corecore